Advertisement

Neurotransmission: sites at which drugs modify neurotransmission

  • Zygmunt L. Kruk
  • Christopher J. Pycock
Chapter
  • 72 Downloads

Abstract

The idea that nerves may communicate with other cells by releasing small quantities of chemicals at their junctions may have arisen from observations of the effects of poisons on animals. It was found that some poisons could mimic the effects of stimulating certain nerves, and it must have occurred to somebody that nerves release chemicals in response to stimulation. Histological studies showed that there is always a gap between the nerve ending and the target tissue, and that this gap must be crossed if the signal from the nerve is to reach its target.

Keywords

Tyrosine Hydroxylase Nerve Terminal Axonal Transport Secondary Messenger Presynaptic Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. Bowmer, CJ. and Yate, M.S. (1989) Therapeutic potential for new selective adenosine receptor ligands and metabolism inhibitors. TIPS, 10, No. 9.Google Scholar
  2. Boyer, J.L., Hepler, J.R. and Harden, T.K. (1989) Hormone and growth factor receptor-mediated regulation of phospholipase C activity. TIPS, 10, No. 9.Google Scholar
  3. British National Formulary. (BNF) New Edition about every 9 months. Short reviews of currently available medical treatments discussed in relation to physiological systems plus comprehensive listing of available medicines.Google Scholar
  4. Catterall, W.A. (1988) Structure and function of voltage sensitive ion channels. Science, 242, 50–61.PubMedCrossRefGoogle Scholar
  5. Cooper, J.R., Bloom, F.E. and Roth, R. (1988) The Biochemical Basis of Neuropharmacology. Oxford University Press, Oxford.Google Scholar
  6. Godfraind, T. and Govoni, S. (1989) Increasing complexity revealed in regulation of Ca2+ antagonist receptor. TIPS, 10, No. 8.Google Scholar
  7. Iversen, L.L. and Goodman, E. (Eds) (1986) Fast and Slow Signalling in the Nervous System. Oxford University Press, Oxford.Google Scholar
  8. Rang, H.P. and Dale, M.M. (1987) Pharmacology. Churchill Livingstone, Edinburgh.Google Scholar
  9. Rogers, H.J., Spector, R.G. and Trounce, J.R. (1986) Textbook of Clinical Pharmacology. Hodder & Stoughton, London.Google Scholar
  10. Snyder, S.H. and Bennet, J.P. (1976) Neurotransmitter receptors in the brain: Biochemical identification. Ann. Rev. Physiol., 38, 153–175.CrossRefGoogle Scholar
  11. Spedding, M. (1987) Three types of Ca2+ channel explain discrepancies. TIPS, 8, No. 4.Google Scholar
  12. Starke, K., Gothert, M. and Kilbinger, H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 865–989.Google Scholar
  13. Trends in Pharmacological Science (1987) Vol. 8, issue 12: A Feast of Short Reviews Celebrating 100 issues of TIPS.Google Scholar
  14. ibid. January, 1991. Receptor nomenclature supplement (to be updated annually).Google Scholar

Copyright information

© Zygmunt L. Kruk and Christopher J. Pycock 1991

Authors and Affiliations

  • Zygmunt L. Kruk
    • 1
  • Christopher J. Pycock
    • 2
  1. 1.Department of Pharmacology Queen Mary and Westfield CollegeUniversity of LondonUK
  2. 2.Derriford HospitalPlymouthUK

Personalised recommendations